A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Provider Prompt & Patient Outreach and Education.
- Who it may be relevant to
- Registry conditions: Lung Cancer. Basic parameters: 50 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening
Overview
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Detailed description
The proposed study will target two key levels of influence in the healthcare setting: provider and patient behavior in order to address disparities between African American and whites in lung screening awareness and utilization. Guided by NIH's Health Disparities Research Framework and building on the formative work conducted in the K99 phase, we will conduct a quasi-experimental study (pretest-posttest, with a nonequivalent control group) in partnership with four primary care clinics within the MedStar Health system in the R00 phase.
Interventions
- Behavioral Provider Prompt & Patient Outreach and Education
To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior
Primary outcome measures
- provider-patient discussion [Time frame: 1-week post-visit]
- lung cancer screening intentions [Time frame: 1-week post-visit]
- lung cancer screening knowledge [Time frame: 1-week post-visit]
Secondary outcome measures (2)
- lung cancer screening referrals [Time frame: 6-months]
- lung cancer screening completion rates [Time frame: 6-months]
Eligibility criteria
Inclusion criteria
- 50-80 years old;
- current cigarette smoker or quit within 15 years;
- a 20+ pack-year smoking history;
- non-adherent to lung screening (>13 months);
- English-speaking;
- scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
- able and willing to provide meaningful consent and complete telephone interviews
Exclusion criteria
- Individuals with a history of lung cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Screening
Study locations
United States · 1 center
- MedStar Health — Washington D.C.
Publications
- Williams RM, Whealan J, Sangraula A, Taylor KL, Adams-Campbell L, Miller KE, Glassmeyer K, Yee P, Camidge K, Foley K, Luta G, Lin KW, Barnes R, DuBoyce WF. Providing Reminders and Education Prior to lung cancer screening: Feasibility and acceptability of a multilevel approach to address disparities in lung cancer screening. Transl Behav Med. 2025 Jan 16;15(1):ibaf008. doi: 10.1093/tbm/ibaf008. PMID 40231692
- Williams RM, Whealan J, Taylor KL, Adams-Campbell L, Miller KE, Foley K, Luta G, Brandt H, Glassmeyer K, Sangraula A, Yee P, Camidge K, Blumenthal J, Modi S, Kratz H. Multilevel approaches to address disparities in lung cancer screening: a study protocol. Implement Sci Commun. 2024 Feb 16;5(1):15. doi: 10.1186/s43058-024-00553-4. PMID 38365820
Identifiers
NCT: NCT04675476 · STUDY00003277